TY - JOUR
T1 - Value-engineered translation for regenerative medicine
T2 - Meeting the needs of health systems
AU - Bubela, Tania
AU - McCabe, Christopher
PY - 2013/12/1
Y1 - 2013/12/1
N2 - Despite high expectations of economic returns, large investments in regenerative medicine technology have yet to materialize, partly due to a lack of proven business and investment models, regulatory hurdles, and a greater focus on cost-effectiveness for reimbursement decisions by payors. Adoption of new economic modeling methods will better link investment decisions to value-based criteria of health systems.
AB - Despite high expectations of economic returns, large investments in regenerative medicine technology have yet to materialize, partly due to a lack of proven business and investment models, regulatory hurdles, and a greater focus on cost-effectiveness for reimbursement decisions by payors. Adoption of new economic modeling methods will better link investment decisions to value-based criteria of health systems.
UR - http://www.scopus.com/inward/record.url?scp=84890935229&partnerID=8YFLogxK
U2 - 10.1089/scd.2013.0398
DO - 10.1089/scd.2013.0398
M3 - Article
C2 - 24304083
AN - SCOPUS:84890935229
SN - 1547-3287
VL - 22
SP - 89
EP - 93
JO - Stem Cells and Development
JF - Stem Cells and Development
IS - SUPPL.1
ER -